Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.75 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | CARM1 | Q86X55 | 2/20 | 0.38 |
| ▸ | PRMT6 | Q96LA8 | 2/20 | 0.38 |
| ▸ | PRMT8 | Q9NR22 | 2/20 | 0.38 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.38 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1612176 | 1.00 | — | — | |
| SCHEMBL22691893 | 0.97 | ALOX15 (0.81) | ALOX15HRH3POLBACE2KEAP1 | |
| Hydrochloric Acid SCHEMBL3671864 | 0.94 | ALOX15 (0.77) | ALOX15HRH3POLBACE2KEAP1 | |
| SCHEMBL82264 | 0.93 | — | — | |
| SCHEMBL7672268 | 0.93 | — | — | |
| SCHEMBL6180747 | 0.90 | — | — | |
| Hydrochloric Acid SCHEMBL9031336 | 0.90 | ALOX15 (0.71) | ALOX15HRH3POLBACE2KEAP1 | |
| SCHEMBL5663473 | 0.90 | ALOX15 (0.71) | ALOX15HRH3POLBACE2SMN1; SMN2 | |
| Bromide SCHEMBL6373609 | 0.90 | — | — | |
| Bromide SCHEMBL9281172 | 0.90 | ALOX15 (0.71) | ALOX15HRH3POLBACE2KEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7947703-B2 | Phenanthridinium derivatives as DNA binding agents | UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW (GB) | 2011-05-24 | — | — | US | claimed |
| US-20070249652-A1 | Phenanthridinium Derivatives as Dna Binding Agents | UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW (GB) | 2007-10-25 | — | — | US | claimed |
| EP-1692130-B1 | PHENANTHRIDINIUM DERIVATIVES AS DNA BINDING AGENTS | UNIV GLASGOW (GB) | 2007-08-08 | — | — | EP | claimed |
| EP-1692130-A2 | PHENANTHRIDINIUM DERIVATIVES AS DNA BINDING AGENTS | University Court of The University of Glasgow (GB) | 2006-08-23 | — | — | EP | claimed |
| WO-2005054241-A2 | PHENANTHRIDINIUM DERIVATIVES AS DNA BINDING AGENTS | THE UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW (GB) | 2005-06-16 | — | — | WO | claimed |
| US-7947703-B2 | Phenanthridinium derivatives as DNA binding agents | UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW (GB) | 2011-05-24 | — | — | US | disclosed |
| US-20070249652-A1 | Phenanthridinium Derivatives as Dna Binding Agents | UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW (GB) | 2007-10-25 | — | — | US | disclosed |
| EP-1692130-B1 | PHENANTHRIDINIUM DERIVATIVES AS DNA BINDING AGENTS | UNIV GLASGOW (GB) | 2007-08-08 | — | — | EP | disclosed |
| EP-1692130-A2 | PHENANTHRIDINIUM DERIVATIVES AS DNA BINDING AGENTS | University Court of The University of Glasgow (GB) | 2006-08-23 | — | — | EP | disclosed |
| WO-2005054241-A2 | PHENANTHRIDINIUM DERIVATIVES AS DNA BINDING AGENTS | THE UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW (GB) | 2005-06-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249652-A1 | Phenanthridinium Derivatives as Dna Binding Agents | DNA2, DDB1, TOP2B | ALOX15 4840/4885HRH3 52/4885POLB 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.